Stifel Financial’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,684
| Closed | -$20.1K | – | 3516 |
|
|
2024
Q4 | $20.1K | Sell |
14,684
-255,084
| -95% | -$349K | ﹤0.01% | 3355 |
|
|
2024
Q3 | $583K | Buy |
269,768
+135,148
| +100% | +$292K | ﹤0.01% | 2576 |
|
|
2024
Q2 | $512K | Buy |
134,620
+2,186
| +2% | +$8.31K | ﹤0.01% | 2610 |
|
|
2024
Q1 | $412K | Buy |
132,434
+82,168
| +163% | +$256K | ﹤0.01% | 2725 |
|
|
2023
Q4 | $167K | Sell |
50,266
-91,638
| -65% | -$304K | ﹤0.01% | 3089 |
|
|
2023
Q3 | $309K | Buy |
141,904
+65,144
| +85% | +$142K | ﹤0.01% | 2776 |
|
|
2023
Q2 | $316K | Buy |
76,760
+41,243
| +116% | +$170K | ﹤0.01% | 2792 |
|
|
2023
Q1 | $183K | Sell |
35,517
-175
| -0.5% | -$903 | ﹤0.01% | 3070 |
|
|
2022
Q4 | $211K | Sell |
35,692
-5,003
| -12% | -$29.5K | ﹤0.01% | 2959 |
|
|
2022
Q3 | $390K | Sell |
40,695
-1,800
| -4% | -$17.3K | ﹤0.01% | 2580 |
|
|
2022
Q2 | $439K | Buy |
42,495
+595
| +1% | +$6.15K | ﹤0.01% | 2542 |
|
|
2022
Q1 | $566K | Buy |
41,900
+1,850
| +5% | +$25K | ﹤0.01% | 2510 |
|
|
2021
Q4 | $655K | Buy |
40,050
+2,100
| +6% | +$34.3K | ﹤0.01% | 2432 |
|
|
2021
Q3 | $676K | Buy |
+37,950
| New | +$676K | ﹤0.01% | 2392 |
|